Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Xos, Inc.Xos, Inc. Reports $55.96 Million Revenue with 26% Growth, Faces Financial Challenges
byNordic Acquisition CorpbyNordic Acquisition Corporation Reports $206K Net Loss for Fiscal Year 2024
MESA ROYALTY TRUST/TXMesa Royalty Trust Reports 80% Decline in Royalty Income for Fiscal Year 2024
Babcock & Wilcox Enterprises, Inc.Babcock & Wilcox Reports $717.3M Revenue Decline, Increases Operating Income
Super League Enterprise, Inc.Super League Enterprise Reports 35% Revenue Decline and $16.6 Million Net Loss for Fiscal Year 2024
Provident Bancorp, Inc. /MD/Provident Bancorp Reports $7.3 Million Net Income, 33.8% Decrease for Fiscal Year 2024
VASO CorpVaso Corporation Reports $86.8 Million Revenue with Decline in Net Income for Fiscal Year 2024
ADM ENDEAVORS, INC.ADM Endeavors Reports 11% Revenue Growth to $5.76 Million for Fiscal Year 2024
Traws Pharma, Inc.Onconova Therapeutics Reports $166.5 Million Net Loss and Financial Challenges in 2024
RetinalGenix Technologies Inc.RetinalGenix Technologies Reports $4.32 Million Net Loss and Seeks Funding for Product Development
Cartesian Growth Corp IICartesian Growth Corporation II Reports Decrease in Net Income to $8.2 Million for Fiscal Year 2024
REGO PAYMENT ARCHITECTURES, INC.REGO Payment Architectures Reports $11.6 Million Net Loss for Fiscal Year 2024
Change Agents Corporation.Avalon GloboCare Reports 52.7% Reduction in Net Losses for Fiscal Year 2024
Carisma Therapeutics Inc.Carisma Therapeutics Reports $60.5M Net Loss for 2024, Collaboration Revenues Increase
FIRST CAPITAL INCFirst Capital, Inc. Reports Decrease in Net Income for Fiscal Year 2024
Humacyte, Inc.Humacyte Reports $148.7 Million Net Loss for 2024, FDA Approves Symvess™
Scilex Holding CoScilex Holding Company Reports $72.8 Million Net Loss for 2024, Revenue Increases to $56.6 Million
Galera Therapeutics, Inc.Galera Therapeutics Reports Decline in Financial Performance and Strategic Acquisition of Nova Pharmaceuticals
XMax Inc.Nova LifeStyle Reports $5.56 Million Net Loss and 13% Decline in Sales for Fiscal Year 2024
Petros Pharmaceuticals, Inc.Petros Pharmaceuticals Reports Revenue Decline and Strategic Shift Amid Financial Challenges
Reborn Coffee, Inc.Reborn Coffee Reports $5.93 Million Revenue with 7.6% Growth and $4.81 Million Net Loss for 2024
Metal Sky Star Acquisition CorpMetal Sky Star Acquisition Corporation Reports Working Capital Deficit and Decreased Net Income
Harvard Apparatus Regenerative Technology, Inc.Harvard Apparatus Regenerative Technology Reports 2024 Financial Results with Revenue Growth and Operating Losses
VOLITIONRX LTDVolitionRx Reports 59% Revenue Growth to $1.23 Million for Fiscal Year 2024
OMEROS CORPOmeros Corporation Reports $156.8 Million Net Loss for 2024, Focuses on Product Pipeline